Sugi Predict

Sugi Predict / Compounds / Phosphorylethanolamine

Phosphorylethanolamine

Phosphorylethanolamine

SCHEMBL2267497

NC(=O)CCCc1ccc(N2C(=O)C=CC2=O)cc1.NCCOP(=O)(O)O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 6/20 0.44
▸ FAAH O00519 3/20 0.44
▸ S1PR1 P21453 6/20 0.36
▸ HSP90AA1 P07900 2/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ CACNA1B Q00975 1/20 0.35
▸ APBA1 Q02410 1/20 0.35
▸ DDAH1 O94760 1/20 0.35
▸ PKM P14618 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ S1PR3 Q99500 4/20 0.34
▸ PPARG P37231 1/20 0.34
▸ S1PR5 Q9H228 1/20 0.34
▸ S1PR2 O95136 1/20 0.33
▸ S1PR4 O95977 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL741572 0.83 MGLL (0.59) MGLLFAAHHSP90AA1NPSR1TDP1
Water SCHEMBL17644778 0.82 MGLL (0.58) MGLLFAAHHSP90AA1NPSR1TDP1
Hydrazine SCHEMBL27822007 0.73 MGLL (0.56) MGLLFAAHHSP90AA1NPSR1TDP1
SCHEMBL8090506 0.73 MGLL (0.56) MGLLFAAHHSP90AA1NPSR1TDP1
SCHEMBL514697 0.72 MGLL (0.59) MGLLFAAHHSP90AA1NPSR1TDP1
SCHEMBL15811640 0.72 MGLL (0.49) MGLLFAAHALDH1A1PKM
Hydrochloric Acid SCHEMBL28737900 0.71 MGLL (0.58) MGLLFAAHHSP90AA1NPSR1TDP1
SCHEMBL12683541 0.71 MGLL (0.62) MGLLFAAHHSP90AA1NPSR1TDP1
SCHEMBL12657331 0.71 MGLL (0.58) MGLLFAAHHSP90AA1NPSR1TDP1
SCHEMBL44044 0.71 MGLL (0.54) MGLLFAAHHSP90AA1NPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003078-B2 Targeted MR imaging agents BARNES-JEWISH HOSPITAL (US) 2011-08-23 — — US disclosed
US-20080247943-A1 Blood Clot-Targeted Nanoparticles KEREOS, INC. 2008-10-09 — — US disclosed
EP-1539252-A4 BLOOD CLOT-TARGETED NANOPARTICLES BARNES JEWISH HOSPITAL (US) 2008-03-12 — — EP disclosed
WO-2007115115-A2 TARGETED MR IMAGING AGENTS KEREOS, INC. (US) 2007-10-11 — — WO disclosed
US-20070237721-A1 TARGETED MR IMAGING AGENTS KEREOS, INC. 2007-10-11 — — US disclosed
US-20070202040-A1 Blood clot-targeted nanoparticles BARNES-JEWISH HOSPITAL (US) 2007-08-30 — — US disclosed
EP-1539252-A2 BLOOD CLOT-TARGETED NANOPARTICLES Barnes-Jewish Hospital (US) 2005-06-15 — — EP disclosed
WO-2004017907-A2 BLOOD CLOT-TARGETED NANOPARTICLES BARNES-JEWISH HOSPITAL (US) 2004-03-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080247943-A1 Blood Clot-Targeted Nanoparticles FGB, PLAT, PLG MGLL 164/4885FAAH 67/4885S1PR1 242/4885
US-20070237721-A1 TARGETED MR IMAGING AGENTS TSPO, ARNT, RXFP4 MGLL 1683/4885FAAH 1865/4885S1PR1 134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.